Diabetes Technology Society is ranked among disease & disorders organizations in Burlingame, CA, with an America's Best Score of 69 out of 100, based on its 2025 Form 990.
Diabetes Technology Society is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G80). Contributions are tax-deductible.
533 Airport Blvd Ste 400, Burlingame, CA 94010-2013
Among the 5 scored disease & disorders organizations in Burlingame, Diabetes Technology Society holds 10.4 months of operating reserves (peer median 29.3 months), runs a typical yearly surplus of 8.4% (peers: surplus of 8.4%), and has grown spending 8.4% a year (peers: grown spending 7.4% a year).
In fiscal year 2025 it reported $1,029,388 in revenue and $1,615,150 in expenses, with contributions making up 18.6% of revenue.
To facilitate research into the treatment, monitoring, diagnosis and prevention of diabetes.
Main program · fiscal year 2025
To further education professionals and the public on the treatment, monitoring, diagnosis and prevention of diabetes. This was achieved by holding educational conferences, maintaining an informational website, holding an ongoing podcast with leaders in the diabetes technology field, maintaining a Spanish/English dual-language informational website and publishing 204 technical articles and 13 resea… Read more
To further education professionals and the public on the treatment, monitoring, diagnosis and prevention of diabetes. This was achieved by holding educational conferences, maintaining an informational website, holding an ongoing podcast with leaders in the diabetes technology field, maintaining a Spanish/English dual-language informational website and publishing 204 technical articles and 13 research articles about diabetes and diabetes technology. Conferences held in 2025, the number of attendees and other projects are as follows:1.tools to distinguish t1d & t2d in adults (tools project)meeting #1: 2/4/2025, 14 Attendeesmeeting #2: 2/5/2025, 14 Attendeesmeeting #3: 5/29/2025: 29 Attendeesmeeting #4: 8/13/2025, 14 Attendees2. Integration of connected diabetes device data into the electronic health record #2 (icode-2)September 18, 2025no. Of attendees: 403. The role of the glycemia risk index diabetes technology meeting (gri meeting)October 27, 2025no. Of attendees: 484. Diabetes technology meeting (in-person) (dtm 2025)October 28-30, 2025no. Of attendees: 5005. The use of cgm to diagnose stage 2 t1d consensus panel (in-person presentation at the 2025 dtm)October 30, 2025 no. Of attendees: 500Ongoing projects:1. Diabetes research hub (drh) - ongoing projectthe drh is a comprehensive data ecosystem designed to accelerate breakthroughs in diabetes research. We empower researchers by unlocking the potential of data trapped in proprietary medical devices and health systems. By creating a secure and user-friendly platform for data collection, analysis, and collaboration, the drh fuels next-generation research using ai and ml to develop personalized and effective solutions for diabetes.2. The dcb open innovation challengein collaboration with diabetes center berneongoing - launched on 4/1/2024 & featured at the dtm 2025 on 10/30/20253. Diabetes technology report(dts podcast)dts launched an ongoing podcast with leaders in the diabetes technology field.4. Saluddiabetes.orgdts launched a Spanish/English dual-language website that summarizes recent publications in diabetes and health for the layperson.5. Optimizing lifestyle interventions for reversing insulin resistance - ongoing projectto analyze medical literature for interventions that improve insulin sensitivity (either by an effect on the liver, muscles, or production of insulin or natural glp-1ra hormone) that could become part of a behavioral tool to be used for people with prediabetes or who are at risk of diabetes to decrease their risk of developing type 2 diabetes.6. Jdst (journal of diabetes science and technology)published 204 technical articles about diabetes and diabetes technology after receiving 628 articles to review.7. Publication of 13 research articles by dts staff listed below:-evaluating the clinical utility of the glycemia risk index.j diabetes sci technol. 2025 Oct 14:19322968251382604. Doi: 10.1177/19322968251382604. Online ahead of print. Pmid: 41216978 Free pmc article.-machine learning to diagnose complications of diabetes. J diabetes sci technol. 2025 Nov;19(6):1650-1670. Doi: 10.1177/19322968251365245. Epub 2025 sep 11. Pmid: 40932163 Free pmc article. Review.-continuous glucose monitoring data analysis 2.0: Functional data pattern recognition and artificial intelligence applications. J diabetes sci technol. 2025 Nov;19(6):1515-1527. Doi: 10.1177/19322968251353228. Epub 2025 aug 14. Pmid: 40814224 Free pmc article.-glucagon-like peptide-1 receptor agonists and peri-procedural aspiration risk. J endocr soc. 2025 Jul 10;9(9):bvaf088. Doi: 10.1210/Jendso/bvaf088. Ecollection 2025 sep. Pmid: 40893948 Free pmc article. Review.-the need to transition from paper to electronic instructions for use for diabetes devices. Npj digit med. 2025 Jun 13;8(1):356. Doi: 10.1038/S41746-025-01720-0. Pmid: 40514391 Free pmc article.-diabetes devices: A growing environmental burden. Diabetes res clin pract. 2025 Aug;226:112307. Doi: 10.1016/J.diabres.2025.112307. Epub 2025 jun 3. Pmid: 40473032 No abstract available.-use of continuous glucose monitoring to diagnose stage 2 type 1 diabetes. J diabetes sci technol. 2025 Jul;19(4):1109-1127. Doi: 10.1177/19322968251333441. Epub 2025 may 30. Pmid: 40444471 Free pmc article. Review.-envisioning tools to help classify type 1 diabetes and type 2 diabetes in new-onset adult diabetes. J diabetes sci technol. 2025 Jul;19(4):1137-1143. Doi: 10.1177/19322968251329055. Epub 2025 mar 28. Pmid: 40152433 Free pmc article.-quantifying environmental waste from diabetes devices in the U.S. Diabetes care. 2025 Jul 1;48(7):1198-1203. Doi: 10.2337/Dc24-2522. Pmid: 40072890.-How to provide additional oversight to ensure that remote patient monitoring for people with diabetes is being used and billed appropriately. Diabetes sci technol. 2025 May;19(3):843-849. Doi: 10.1177/19322968241309357. Epub 2025 jan 16. Pmid: 39819165 Free pmc article.-how the diabetes research hub will modernize and enhance diabetes data utilization. J diabetes sci technol. 2026 Jan;20(1):3-6. Doi: 10.1177/19322968241306129. Epub 2024 dec 21. Pmid: 39707843 Free pmc article.-comparison of the glycemia risk index and time in range in a case series of using automated insulin delivery to improve glycemic control in people with type 1 diabetes and end stage kidney disease on hemodialysis. Diabetes res clin pract. 2025 Jan;219:111940. Doi: 10.1016/J.diabres.2024.111940. Epub 2024 nov 29. Pmid: 39615793 No abstract available.-consensus report on the use of continuous glucose monitoring in chronic kidney disease and diabetes. J diabetes sci technol. 2025 Jan;19(1):217-245. Doi: 10.1177/19322968241292041. Epub 2024 nov 29. Pmid: 39611379 Free pmc article.
$1,401,081 spent
Where each dollar went · fiscal year 2025
Of every dollar it spent, 87¢ went to programs, 13¢ to management and 0¢ to fundraising.
Programs $1,401,081
Management $214,069
Fundraising $0
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
87%
Meets
Compared with Burlingame peers
Measure
This organization
Peer median
Operating reserves
10.4 mo
29.3 mo
Typical margin
+8.4%
+8.4%
Spending growth
+8.4% / yr
+7.4% / yr
Debt load
1.4%
0.5%
Peers: the 5 Burlingame disease & disorders organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$1,029,388Fiscal year 2025
Expenses$1,615,150Fiscal year 2025
Total assets$1,420,913Fiscal year 2025
Total liabilities$20,362Fiscal year 2025
Fiscal year ending December2025
Revenue$1,029,388
Expenses$1,615,150
Net income−$585,762
Net assets$1,400,551
Notable sources of revenue
Percent of total revenue
Contributions
$191,000
18.6%
Program services
$792,044
76.9%
Investment income
$46,344
4.5%
Other (net)
$0
0.0%
Assets / debt
Total assets
$1,420,913
Total liabilities
$20,362
Net assets
$1,400,551
Compensation
Not in our extract for this year.
Fiscal year ending December2024
Revenue$1,925,694
Expenses$1,539,248
Net income$386,446
Net assets$1,986,313
Notable sources of revenue
Percent of total revenue
Contributions
$1,290,363
67.0%
Program services
$535,680
27.8%
Investment income
$98,426
5.1%
Other (net)
$1,225
0.1%
Assets / debt
Total assets
$2,007,874
Total liabilities
$21,561
Net assets
$1,986,313
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$1,379,124
Expenses$1,103,400
Net income$275,724
Net assets$1,599,194
Notable sources of revenue
Percent of total revenue
Contributions
$967,906
70.2%
Program services
$371,507
26.9%
Investment income
$38,517
2.8%
Other (net)
$1,194
0.1%
Assets / debt
Total assets
$1,611,702
Total liabilities
$12,508
Net assets
$1,599,194
Compensation
Officers and key employees
$297,813
Share of expenses
27.0%
Fiscal year ending December2022
Revenue$1,163,946
Expenses$1,267,548
Net income−$103,602
Net assets$1,323,470
Notable sources of revenue
Percent of total revenue
Contributions
$738,153
63.4%
Program services
$418,745
36.0%
Investment income
$7,048
0.6%
Other (net)
$0
0.0%
Assets / debt
Total assets
$1,334,588
Total liabilities
$11,118
Net assets
$1,323,470
Compensation
Officers and key employees
$607,813
Share of expenses
48.0%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?